Clinical trial
Treatment Refractory Panic Disorder
NCT00118417 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Refractory Panic Disorder
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 1999
- Completion date
- October 31, 2007
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.